Sign In
Buy MRNA
$59.81
+0.640 (+1.08%)
At Close: Aug 10, 2026
Moderna trims top end of full-year forecast on weak COVID vaccine sales
07:11am, Thursday, 06'th Nov 2025
Moderna lowered the top end of its 2025 revenue forecast by $200 million on Thursday, citing weaker-than-expected sales of its COVID-19 vaccine in the U.S. as Americans struggled to access the shots.
Moderna Swings to a Loss on Fewer Covid-19 Vaccine Sales
07:09am, Thursday, 06'th Nov 2025
Moderna swung to a loss and logged lower sales in the third quarter as it works to expand its offerings amid weakening demand for its Covid-19 vaccine.
Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates
07:00am, Thursday, 06'th Nov 2025
Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected revenue range to $1.6 - $2.0 billion Improves 2025 expected GAAP operating
Should You Buy Moderna Stock Ahead of Q3 Earnings Report?
09:41am, Tuesday, 04'th Nov 2025
MRNA is likely to have faced earnings pressure and pipeline setbacks as waning COVID-19 vaccine demand weighs on its outlook.
Bessemer Group Inc. Sells 3,655 Shares of Moderna, Inc. $MRNA
04:03am, Tuesday, 04'th Nov 2025
Bessemer Group Inc. lessened its holdings in Moderna, Inc. (NASDAQ: MRNA) by 31.5% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,949
Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma
07:00am, Monday, 03'rd Nov 2025
CAMBRIDGE, MA / ACCESS Newswire / November 3, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the Company's investigational
Moderna: Focus On Cancer Vaccines, Not Buyout
04:05pm, Friday, 31'st Oct 2025
Moderna surged on reports of talks with a large biopharma for a potential partnership or buyout, despite trading at multi-year lows. MRNA's promising cancer vaccine data and surprising findings on mRN
Moderna (MRNA) Stock Is Trading Lower Friday: What's Going On?
03:57pm, Friday, 31'st Oct 2025
Moderna Inc (NASDAQ:MRNA) shares are trading lower on Friday afternoon, giving back a portion of the gains seen on Thursday. Here's what investors need to know.
Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know
10:00am, Friday, 31'st Oct 2025
Recently, Zacks.com users have been paying close attention to Moderna (MRNA). This makes it worthwhile to examine what the stock has in store.
Strength Seen in Moderna (MRNA): Can Its 13.9% Jump Turn into More Strength?
06:01am, Friday, 31'st Oct 2025
Moderna (MRNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
S&P 500 Gains and Losses Today: Meta Stock Drops After Earnings; Moderna Surges
05:25pm, Thursday, 30'th Oct 2025
Shares of a social media juggernaut slumped as investors balked at its rapidly accelerating spending on artificial intelligence, while reports of potential partnership or buyout talks helped a vaccine
Earnings Preview: Moderna (MRNA) Q3 Earnings Expected to Decline
11:06am, Thursday, 30'th Oct 2025
Moderna (MRNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Moderna (MRNA) Outperforms Broader Market: What You Need to Know
06:45pm, Friday, 24'th Oct 2025
Moderna (MRNA) reached $26.74 at the closing of the latest trading day, reflecting a +1.87% change compared to its last close.
Moderna Named a Top Employer by Science for Eleventh Consecutive Year
02:42pm, Thursday, 23'rd Oct 2025
CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked as a top employer in the global biopharmaceutical industry in Science and Science Careers
Moderna to Host Investor Event - Analyst Day
07:00am, Thursday, 23'rd Oct 2025
CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - Analyst Day at 9:00 a.m. ET on Thursday, November 20, 2025.
